In-vivo labeling of retinal amyloid-beta(Aβ) and tau has potential as non-invasive biomarker for Alzheimer’s disease (AD). However, literature on the presence of Aβ and phosphorylated tau (pTau) in AD retinas …

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...